N/A
N=46
Hair Care Product Use Among Women Of Color
Breast Cancer · Pregnancy Related · Exposure During Pregnancy
Bottom Line
View on ClinicalTrials.gov: NCT04493892 ↗Enrolled (actual)
46
Serious AEs
0.0%
Results posted
May 2024
Primary outcome: Primary: Change in Internal Dose of Urinary Phthalate Metabolites — 1.9 percent change of sumLMW
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Educational Intervention (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Female
- Sponsor
- Columbia University
- Primary completion
- Dec 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Internal Dose of Urinary Phthalate Metabolites |
-16.5 | — |
| PRIMARY Change in Internal Dose of Urinary Phthalate Metabolites |
-16.5 | — |
| SECONDARY Number of Participants With a Change in PAPM Stage |
5 | — |
| SECONDARY Number of Participants With a Change in PAPM Stage |
5 | — |
| SECONDARY Number of Participants With a Change in PAPM Stage |
5 | — |
Summary
The purpose of this study is to reduce use of personal care products that contain endocrine disrupting chemicals among women. For this pilot intervention, the investigators focus on the hair care product class of personal care products, the reduction in use of phthalate-containing Hair Care Products (HCPs) and use among pregnant Women of Color (WOC).
Eligibility Criteria
Inclusion Criteria
- English and/or Spanish Speaking
- Pregnant women within first 4 weeks of 3rd trimester of pregnancy
- Lives within Northern Manhattan
- Women of color defined as Black or Hispanic women
Exclusion Criteria
- Does not provide consent
Data sourced from ClinicalTrials.gov (NCT04493892). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.